Stocks | |||||
The table gives an overview of all stocks, alphabetically sorted. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Name | Symbol | Analysis date | Close | +/- % |
Amplitech Group | AMPG | Nov 12, 2024 | 0.89 | -0.12 |
Amplitude A | AMPL | Nov 12, 2024 | 10.50 | +2.14 |
Amprius Technologies | AMPX | Nov 12, 2024 | 2.51 | +2.45 |
AMREP | AXR | Nov 12, 2024 | 35.58 | +2.80 |
AMTD Digital ADR | HKD | Nov 12, 2024 | 2.98 | -0.33 |
AMTD Idea Group ADR | AMTD | Nov 12, 2024 | 1.19 | -1.65 |
Amtech Systems | ASYS | Nov 12, 2024 | 5.75 | +0.35 |
Amylyx Pharmaceuticals | AMLX | Nov 12, 2024 | 6.24 | -11.24 |
AN2 Therapeutics | ANTX | Nov 12, 2024 | 1.06 | -2.75 |
Analog Devices | ADI | Nov 12, 2024 | 219.55 | -0.42 |
AnaptysBio | ANAB | Nov 12, 2024 | 21.50 | -4.02 |
Anavex Life Sciences | AVXL | Nov 12, 2024 | 9.02 | -1.42 |
Andretti Acquisition II | POLE | Nov 12, 2024 | 9.96 | 0.00 |
Andretti Acquisition II Unit | POLEU | Nov 12, 2024 | 10.00 | 0.00 |
Anebulo Pharmaceuticals | ANEB | Nov 12, 2024 | 1.65 | -2.37 |
ANEW Medical | WENA | Nov 12, 2024 | 0.73 | 0.00 |
Angel Oak Financial Strategies | FINS | Nov 12, 2024 | 12.86 | -0.92 |
Angel Oak Mortgage REIT | AOMR | Nov 12, 2024 | 9.91 | -0.30 |
Anghami | ANGH | Nov 12, 2024 | 0.76 | +0.66 |
Angi A | ANGI | Nov 12, 2024 | 1.93 | -26.34 |
AngioDynamics | ANGO | Nov 12, 2024 | 7.14 | -4.03 |
Anglogold Ashanti | AU | Nov 12, 2024 | 24.63 | -1.91 |
Anheuser-Busch InBev ADR | BUD | Nov 12, 2024 | 56.00 | -1.87 |
ANI Pharmaceuticals | ANIP | Nov 12, 2024 | 61.00 | -1.20 |
Anika Therapeutics | ANIK | Nov 12, 2024 | 16.88 | -1.11 |
Anixa Biosciences | ANIX | Nov 12, 2024 | 3.25 | -2.40 |
Annaly Capital Management | NLY | Nov 12, 2024 | 19.48 | -1.77 |
Annaly Capital Management F Pref | NLY-F | Nov 12, 2024 | 25.91 | -0.15 |
Annaly Capital Management G Pref | NLY-G | Nov 12, 2024 | 25.48 | -0.12 |
Annaly Capital Management I Pref | NLY-I | Nov 12, 2024 | 25.77 | -0.03 |
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.